Letermovir Prophylaxis for CMV DNAemia /Disease after HLA ‐Mismatched HSCT : A Retrospective Real‐World Analysis with Overlap Propensity Score Weighting

Documenti analoghi

• Primary Sclerosing Cholangitis in the Absence of Inflammatory Bowel Disease Increases the Risk of Colorectal Cancer: A Multi‐Centre Propensity Score Matched Analysis
  di: Saqr Alsakarneh, et al.
  Pubblicazione: (2025)
• Editorial: HBeAg ‐Positive Chronic Hepatitis B With Low HBsAg Levels—Exploring Clinical Significance of preS2 Deletion Mutations
  di: Ying‐Nan Tsai, et al.
  Pubblicazione: (2025)
• Letter: No Biochemical Relapse Is Associated With the Highest Off‐Therapy HBsAg Loss Rate—Authors' Reply
  di: Ying‐Nan Tsai, et al.
  Pubblicazione: (2025)
• Superior Efficacy of Tenofovir Alafenamide Compared With Entecavir in Reducing Hepatitis B Surface Antigen: A Multicentre Propensity Score‐Matched Study Using Linear Mixed‐Effects Models
  di: Takashi Kumada, et al.
  Pubblicazione: (2026)
• Folinic Acid Prophylaxis and Dose Adjustments Enable Safe Treatment with Pemetrexed in Patients with Renal Impairment
  di: Nikki de Rouw, et al.
  Pubblicazione: (2025)